A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+40.85%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$468M
AUM Growth
+$468M
(+31%)
Cap. Flow
-$16.7M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
97.64%
Holding
17
New
1
Increased
1
Reduced
3
Closed
–
Top Buys
1 |
NCNA
NuCana
NCNA
|
$17.2M |
2 |
VRNA
Verona Pharma
VRNA
|
$9.71M |
Top Sells
1 |
CRISPR Therapeutics
CRSP
|
$21.7M |
2 |
Personalis
PSNL
|
$21.4M |
3 |
Protara Therapeutics
TARA
|
$551K |
Sector Composition
1 | Healthcare | 100% |